orexin 1 antagonists (LITMUS Molecular Design)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameorexin 1 antagonists (LITMUS Molecular Design)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOrexin receptor type 1 antagonists
TargetsOrexin receptor type 1
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLITMUS Molecular Design LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLITMUS Molecular Design LLC
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A